Cytosine Arabinoside in Addition to VCAA-based Protocols for the Treatment of Canine Lymphoma With Bone Marrow Involvement: Does It Make the Difference?
Veterinary and Comparative Oncology - United Kingdom
doi 10.1111/j.1476-5829.2007.00141.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2008
Authors
Publisher
Wiley